Abstract
Parkinson's disease is the second most common neurodegenerative disorder and affects people from all ethnic backgrounds, yet little is known about the genetics of Parkinson's disease in non-European populations. In addition, the overall identification of copy number variants at a genome-wide level has been understudied in Parkinson's patients. The objective of this study was to understand the genome-wide burden of copy number variants in Latinos and its association with Parkinson's disease. We used genome-wide genotyping data from 747 Parkinson's disease patients and 632 controls from the Latin American Research Consortium on the Genetics of Parkinson's disease. Genome-wide copy number burden analysis showed that patients were significantly enriched for copy number variants overlapping known Parkinson's disease genes compared with controls (odds ratio, 3.97; 95%CI, 1.69-10.5; P = 0.018). PRKN showed the strongest copy number burden, with 20 copy number variant carriers. These patients presented an earlier age of disease onset compared with patients with other copy number variants (median age at onset, 31 vs 57 years, respectively; P = 7.46 × 10-7 ). We found that although overall genome-wide copy number variant burden was not significantly different, Parkinson's disease patients were significantly enriched with copy number variants affecting known Parkinson's disease genes. We also identified that of 250 patients with early-onset disease, 5.6% carried a copy number variant on PRKN in our cohort. Our study is the first to analyze genome-wide copy number variant association in Latino Parkinson's disease patients and provides insights about this complex disease in this understudied population. © 2020 International Parkinson and Movement Disorder Society.
Highlights
Parkinson’s disease (PD) is the second most common neurodegenerative disorder, and the fastest growing cause of disability due to a neurological disorder in the world 1,2
Using a Cox proportional-hazards regression analysis with age, sex, and the first five ancestry principal components included as covariates, we found that the effect of carrying a copy number variants (CNVs) on a known PD gene on the hazard of age at onset (AAO) was highly significant (HR: 2.42 [1.57 - 3.71], P = 5.70 x 10- 5)
This is important considering that the data for Latino population frequency of CNVs is limited, especially in neurologically healthy adults 43,44.We assessed the CNV burden for different categories and observed an increased burden of CNVs overlapping known PD genes in PD patients
Summary
Parkinson’s disease (PD) is the second most common neurodegenerative disorder, and the fastest growing cause of disability due to a neurological disorder in the world 1,2. The majority of studies do not include individuals of non-European ancestry, creating a large gap in knowledge This is especially true for Hispanics/Latinos (Box 1). Parkinson’s disease is the second most common neurodegenerative disorder and affects people from all ethnic backgrounds, yet little is known about the genetics of Parkinson’s disease in non-European populations. Objectives: To understand the genome-wide burden of copy number variants in Latinos and its association with Parkinson’s disease. Results: Genome-wide copy number burden analysis showed no difference between patients vs controls, whereas patients were significantly enriched for copy number variants overlapping known Parkinson’s disease genes compared to controls (Odds Ratio: 3.97 [1.69 - 10.5], P = 0.018). Our study is the first to analyze genome-wide copy number variants association in Latino Parkinson’s disease patients and provides insights about this complex disease in this understudied population
Sign-in/Register to view highlights & summary Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
